Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Prostate Cancer Treatment and Research, Radiopharmaceutical Chemistry and Applications, and Multiple Myeloma Research and Treatments.
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer
CD4+ CAR T-cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR T-cell therapy
Dysregulation of CD4<sup>+</sup>and CD8<sup>+</sup>resident memory T, myeloid, and stromal cells in steroid-experienced, checkpoint inhibitor colitis
Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes
Single-dose 177Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial
Circulating monocytes associated with anti-PD-1 resistance in human biliary cancer induce T cell paralysis
Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer